Navigation Links
IDRI Collaborates with the Brazilian Butantan Institute To Develop Novel Vaccines Against Leishmaniasis
Date:1/22/2009

SEATTLE, Jan. 22 /PRNewswire/ -- IDRI (Infectious Disease Research Institute) announced it has granted the Instituto Butantan, a Brazilian biomedical research institution, an exclusive license in Latin America and a non-exclusive license in the rest of the world to use two of IDRI's lead vaccine antigen candidates for the prevention and treatment of leishmaniasis in humans and dogs. IDRI will provide technical assistance to the Instituto Butantan for the development and evaluation of the candidate vaccines, and if the trials are successful, IDRI's manufacturing technology and know-how will be transferred to Brazil, where the vaccines will be produced. Under the agreement IDRI will receive royalty payments on future product sales that will assist IDRI's non-profit research and development activities. Further details on the financial terms were not disclosed.

Leishmaniasis is a widespread parasitic illness that has caused epidemics in India, Africa, Latin America and along the Mediterranean coast. Leishmania parasites are transmitted to humans through the bite of infected sandflies. Visceral leishmaniasis, the most severe form of the disease, causes fatal infections of internal organs, while the cutaneous form causes serious disfiguring skin lesions. About 500,000 new cases of visceral leishmaniasis occur each year, and 10% of these patients, who are mostly children, will die.

"For too long, the world has virtually ignored the dramatic burden of leishmaniasis on poor populations and limited efforts have been dedicated to the research of new tools against the disease. Today, we still don't have an effective vaccine to protect people and current treatments are either toxic, difficult to deliver, or prohibitively expensive," said Dr. Isaias Raw, President, Instituto Butantan, Sao Paulo, Brazil.

This agreement is the result of several years of collaborative research between IDRI and Instituto Buta
'/>"/>

SOURCE Infectious Disease Research Institute
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. SpineSmith Partners Collaborates with University of Texas Biomedical Engineering Students to Develop Innovative Products
2. Singulex Collaborates With Large Pharmaceutical Company in Erenna(TM) Technology Access Program
3. NIH collaborates with EPA to improve the safety testing of chemicals
4. GeneGo Collaborates With The Netherlands Toxicogenomics Center on $100 Million Grant
5. NYU Medical Center Collaborates With Rosetta Genomics to Develop a microRNA-Based Diagnostic Test for Melanoma
6. New Online Video Features Brazilian Researcher Elbio Rech
7. New Bill to Expand Promotion of Biofuels Is a Welcome Boost for U.S.-Brazil Relations According to Brazilian Sugarcane Industry
8. Friends of the Earth Report on Biofuel Production Offers Incomplete, Outdated and Inaccurate Picture, According to Brazilian Sugarcane Industry Association
9. Medicsight Receives Brazilian State Food and Drug Administration Approval for ColonCAD Software
10. Brazilian Sugarcane Industry: OECD Report Confirms Overall Benefits of Brazilian Sugarcane Ethanol
11. Brazilian National Biosafety Technical Committee Approves Monsanto Company Insect-Protected Corn Trait
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/10/2009)... Dec. 10 /PRNewswire-FirstCall/ - YM BioSciences Inc. (NYSE ... sciences product development company that identifies and advances ... various stages of development, today provided an update ... the merger of Cytopia Ltd. into YM, details ... The board of directors of Cytopia has unanimously ...
(Date:12/10/2009)... Iowa, Dec. 10 Vivakor, Inc. ... it has entered into an exclusive, $5 ... Regeneca International, Inc. ( www.regeneca.com ). ... rights to a new cutting-edge nutraceutical formulation ... development of future formulations by Vivakor for ...
(Date:12/10/2009)... (NASDAQ: MATK) announced today that it has entered into ... Fonterra Co-operative Group Limited for the use of Martek’s products ... pregnant and nursing mothers. , ... ... Corporation (NASDAQ: MATK) announced today that it has entered ...
(Date:12/10/2009)... Dec. 10 Northwest Biotherapeutics, Inc. ("NWBT" or ... Robert A. Farmer has joined the company,s Board of ... and Harvard Law School, currently serves on six other ... the national treasurer of four presidential campaigns, including those ... Glenn. In those roles, he led fundraising of ...
Breaking Biology Technology:YM BIOSCIENCES OFFER FOR CYTOPIA APPROVED TO PROCEED TO SHAREHOLDER VOTE BY AUSTRALIAN COURT 2YM BIOSCIENCES OFFER FOR CYTOPIA APPROVED TO PROCEED TO SHAREHOLDER VOTE BY AUSTRALIAN COURT 3YM BIOSCIENCES OFFER FOR CYTOPIA APPROVED TO PROCEED TO SHAREHOLDER VOTE BY AUSTRALIAN COURT 4Vivakor Receives $5 Million Licensing and Purchase Agreement for Nutraceutical Products 2Vivakor Receives $5 Million Licensing and Purchase Agreement for Nutraceutical Products 3Martek Signs Sole-Source Supply Agreement with Fonterra 2Martek Signs Sole-Source Supply Agreement with Fonterra 3Northwest Biotherapeutics Announces Appointment of Robert A. Farmer to the Board of Directors 2Northwest Biotherapeutics Announces Appointment of Robert A. Farmer to the Board of Directors 3
... 25 Tengion Inc., a clinical stage regenerative medicine company focused ... Nichtberger, M.D., President and Chief Executive Officer of Tengion, will present ... 2, 2008 at 9:50 a.m. EST at The Palace Hotel in ... About Tengion , , ...
... /PRNewswire-Asia/ -- ScinoPharm, an active,pharmaceutical ingredient (API) specialist, ... entitled "Novel Crystal Forms of Irinotecan,Hydrochloride." The new ... and processes for their preparation as well as,pharmaceutical ... treating,metastatic carcinoma of the colon or rectum using ...
... Nov. 24 3SBio Inc. (Nasdaq: SSRX ... marketing biopharmaceutical products primarily in China,announced that Dr. Yingfei ... 20th Annual Health Care Conference in New York on ... The presentation will be ...
Other Biology Technology:ScinoPharm Granted US Patent for Novel Crystal Forms 2
(Date:12/14/2009)... you are spending the holidays with big Uncle Frank ... be better off with another family, spare a thought ... team from McMaster University and the University of New ... that lives in groups, members make strategic decisions about ... the current issue of Biology Letters . , ...
(Date:12/14/2009)... MODA Technology Partners, a global software ... product testing for the Pharmaceutical industry, today announced ... third generation mobile data acquisition platform. The latest ... automate their regulated manufacturing processes. ,, MODA ... Fully-Configurable Test Methods: Each test method ...
(Date:12/13/2009)... Conn.A team led by Yale University researchers has ... blood for the first time. Their findings, which ... of Nature Nanotechnology , could dramatically simplify ... and other diseases. , The teamled ... Engineering & Applied Science, and Tarek Fahmy, an ...
Breaking Biology News(10 mins):MODA Announces Availability of Third Generation Mobile Data Acquisition Platform 2Scientists use nanosensors for first time to measure cancer biomarkers in blood 2Galil Medical Announces Establishment of Global Headquarters in Minneapolis MN 5093 1Galil Medical Announces Establishment of Global Headquarters in Minneapolis MN 5093 2Article Published in Expert Opinion on Biological Therapy Evaluates StemEx 28R 29 28carlecortemcel l 29 for Leukemia and Lymphoma 5089 1Article Published in Expert Opinion on Biological Therapy Evaluates StemEx 28R 29 28carlecortemcel l 29 for Leukemia and Lymphoma 5089 2Article Published in Expert Opinion on Biological Therapy Evaluates StemEx 28R 29 28carlecortemcel l 29 for Leukemia and Lymphoma 5089 3InteKrin Therapeutics Presents Positive Long Term INT131 Preclinical Cardiovascular Safety Data at the 45th Annual European Association for the Study 5085 1InteKrin Therapeutics Presents Positive Long Term INT131 Preclinical Cardiovascular Safety Data at the 45th Annual European Association for the Study 5085 2
... part of our daily vocabulary. We all know they,re part ... pastas. We know they have something to do with starches ... still a lot for science to learn about them. ... said Nikki Pohl, an Iowa State University associate professor of ...
... have made a major new advance in taking waste heat ... technology that can improve the energy efficiency of diesel engines, ... industry. , This heat-actuated cooling system, which will probably find ... applied to automobiles, factories or other places where waste heat ...
... Washington, D.C.April 1, 2009For the past several decades, evidence ... folate, offers protection against the development of certain common ... new avenues for public health interventions that have a ... an essential factor in DNA synthesis also means that ...
Other Biology News:Iowa State chemist synthesizes carbohydrates, launches startup company 2Breakthrough made in energy efficiency, use of waste heat 2Breakthrough made in energy efficiency, use of waste heat 3Health benefits, consequences of folic acid dependent on circumstances 2
...
Rabbit polyclonal to LCAT ( Abpromise for all tested applications). entrezGeneID: 3931 SwissProtID: P04180...
HAMP Immunogen: HAMP (AAH20612, 25 a.a. ~ 85 a.a) full length recombinant protein with GST tag. Storage: -20 C, Avoid Freeze/Thaw Cycles *Available for distribution in the US only...
... Nabeta2. The epitope specific for ... any other known proteins.,SPECIES REACTIVITIES: ... work on human because the ... (17/19 residues). Reactivity with other ...
Biology Products: